Results 51 to 60 of about 45,992 (237)

Use of drug-coated balloon instead of drug-eluting stent for pediatric cardiac allograft vasculopathy

open access: yesAnnals of Pediatric Cardiology, 2023
Cardiac allograft vasculopathy (CAV) sometimes leads to restenosis, even after percutaneous transcatheter intervention. Recently, drug-coated balloons (DCBs) have been successfully used to treat coronary artery disease, especially CAVs, in adults ...
Masaki Hirose   +5 more
doaj   +1 more source

Excessive Ostial Stent Protrusion: Evaluation of Management Strategies and Clinical Outcomes of the Side Flap Technique

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Backgrounds Accurate stent positioning in aorto‐ostial lesions remains challenging due to complex three‐dimensional anatomy, lack of optimal fluoroscopic projections, and high rates of geographic miss. Stent overhang impairs guide catheter re‐engagement and complicates future revascularization.
Gregor Leibundgut   +7 more
wiley   +1 more source

Identification of Hemodynamically Optimal Coronary Stent Designs Based on Vessel Caliber [PDF]

open access: yes, 2012
Coronary stent design influences local patterns of wall shear stress (WSS) that are associated with neointimal growth, restenosis, and the endothelialization of stent struts.
Gundert, Timothy J   +4 more
core   +1 more source

Simulating Drug-Eluting Stents: Progress Made and the Way Forward [PDF]

open access: yes, 2013
Drug-eluting stents have significantly improved the treatment of coronary artery disease. Compared with their bare metal predecessors, they offer reduced rates of restenosis and thus represent the current gold standard in percutaneous coronary ...
Kennedy, Simon   +5 more
core   +2 more sources

Does lipoprotein (a) level have a predictive value in restenosis after coronary stenting?

open access: yesInternational Journal of Preventive Medicine, 2011
Objectives: Lipid disorders, lipoproteins, diabetes mellitus, and hypertension are the known risk factors for coronary artery diseases; however, their role is unknown in restenosis after coronary stenting.
Alireza Khosravi   +5 more
doaj  

Gene Polymorphisms of the Renin-Angiotensin-Aldosterone System as Risk Factors for the Development of In-Stent Restenosis in Patients with Stable Coronary Artery Disease

open access: yesBiomolecules, 2021
This study investigated the renin-angiotensin-aldosterone system (RAAS) gene polymorphisms as possible genetic risk factors for the restenosis development in patients with drug-eluting stents.
Madina Azova   +6 more
doaj   +1 more source

Successful Management of a Complex Coronary Bifurcation Lesion in Acute Coronary Syndrome Using a Free‐Metal Approach

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT We present the case of a 56‐year‐old male with non‐ST elevation myocardial infarction (NSTEMI) and a complex thrombotic lesion at the ostial left circumflex artery (LCX), extending into bifurcating marginal branches. Due to the high risk of side branch occlusion, a stentless strategy using thrombus aspiration, the reverse wire technique, and ...
Flavius‐Alexandru Gherasie   +1 more
wiley   +1 more source

Perfil dos pacientes submetidos à angioplastia trasluminal coronariana com stents farmacológicos no Instituto de Cardiologia de Santa Catarina. [PDF]

open access: yes, 2007
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Aquino, Vivian Wuerges de
core  

Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass [PDF]

open access: yes, 1999
Objectives: The investigation centers on whether there is a reperfusion-induced specific cardiac inflammatory reaction after bypass surgery. Background: Cardiopulmonary bypass (CPB) leads to systemic inflammation.
Becker, Bernhard F.   +5 more
core   +1 more source

Restenosis after Coronary Stent Implantation: Cellular Mechanisms and Potential of Endothelial Progenitor Cells (A Short Guide for the Interventional Cardiologist)

open access: yesCells, 2022
Coronary stents are among the most common therapies worldwide. Despite significant improvements in the biocompatibility of these devices throughout the last decades, they are prone, in as many as 10–20% of cases, to short- or long-term failure.
Tommaso Gori
doaj   +1 more source

Home - About - Disclaimer - Privacy